ACCESSION: MSBNK-SMB_Measured-HSA032P0344002
RECORD_TITLE: Characterized; Dodecanoylcarnitine; LC-ESI-QTOF; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.25, Processed 2025.02.25, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Yu et al. Front Cell Infect Microbiol. 2022,11,763507
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was characterized at Level 3 automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS3233
COMMENT: DATASET_TITLE The gut microbiome and metabolites are altered and interrelated in patients with rheumatoid arthritis
COMMENT: DATASET_AUTHORS Die Yu, Juping Du, Xia Pu, Liyuan Zheng, Shuaishuai Chen, Na Wang, Jun Li, Shiyong Chen, Shaobiao Pan, Bo Shen
COMMENT: MS1_M/Z_AVERAGED_THRES 15.000
COMMENT: MS2_M/Z_AVERAGED_THRES 20.000
COMMENT: DATASET_FILE_NUM 60
COMMENT: NUM_AVERAGED_SPEC 28
COMMENT: RAW_SPEC {'HC13-pos_2909': {'bp': 14929.0, 'sum': 21574.0}, 'RA4-pos_2792': {'bp': 13716.0, 'sum': 21613.0}, 'HC20-pos_2849': {'bp': 13692.0, 'sum': 21095.0}, 'HC9-pos_2713': {'bp': 13611.0, 'sum': 20730.0}, 'RA12-pos_2974': {'bp': 13307.0, 'sum': 20907.0}, 'RA13-pos_2714': {'bp': 12738.0, 'sum': 20127.0}, 'HC16-pos_2893': {'bp': 10457.0, 'sum': 22204.0}, 'RA4-pos_2802': {'bp': 8997.0, 'sum': 14851.0}, 'HC12-pos_2832': {'bp': 8238.0, 'sum': 13430.0}, 'RA17-pos_2807': {'bp': 6442.0, 'sum': 9638.0}, 'RA15-pos_2913': {'bp': 6197.0, 'sum': 9006.0}, 'RA1-pos_3011': {'bp': 3250.0, 'sum': 6969.0}, 'RA14-pos_2569': {'bp': 3119.0, 'sum': 5556.0}, 'HC13-pos_2868': {'bp': 2623.0, 'sum': 4099.0}, 'HC25-pos_2787': {'bp': 2412.0, 'sum': 3991.0}, 'RA18-pos_2745': {'bp': 2190.0, 'sum': 3617.0}, 'RA23-pos_2705': {'bp': 2152.0, 'sum': 3936.0}, 'HC3-pos_3092': {'bp': 1883.0, 'sum': 3106.0}, 'QC3-pos_2713': {'bp': 1834.0, 'sum': 3618.0}, 'RA15-pos_2859': {'bp': 1611.0, 'sum': 2782.0}, 'HC19-pos_2674': {'bp': 1304.0, 'sum': 2373.0}, 'RA19-pos_2990': {'bp': 1255.0, 'sum': 1969.0}, 'RA2-pos_2897': {'bp': 1194.0, 'sum': 2775.0}, 'HC10-pos_2785': {'bp': 1077.0, 'sum': 2351.0}, 'QC2-pos_2697': {'bp': 1067.0, 'sum': 2342.0}, 'RA16-pos_2688': {'bp': 1003.0, 'sum': 2613.0}, 'QC7-pos_2681': {'bp': 772.0, 'sum': 1690.0}, 'RA21-pos_2486': {'bp': 530.0, 'sum': 1428.0}}
COMMENT: RETENTION_TIME_STDEV 0.023
COMMENT: PRECURSOR_M/Z_RAW 344.278498
COMMENT: PRECURSOR_M/Z_STDEV 0.001261
COMMENT: PRECURSOR_IN_MS1 ND
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 5.940; C18H38N3OP; [M+H]+; delta(ppm) -5.939875
COMMENT: PROPOSED_MF SevenGoldenRules 1.127; C20H33N5; [M+H]+; delta(ppm) -1.127382
COMMENT: PROPOSED_MF SevenGoldenRules 2.767; C19H37NO4; [M+H]+; delta(ppm) 2.767475
COMMENT: PROPOSED_MF SevenGoldenRules 5.780; C13H38N5O3P; [M+H]+; delta(ppm) 5.779653
COMMENT: PROPOSED_MF SevenGoldenRules 14.487; C14H37N3O6; [M+H]+; delta(ppm) 14.487003
COMMENT: PROPOSED_MF MS-FINDER 3.873; C19H37NO4; [M+H]+; delta(ppm) 2.759073
COMMENT: PROPOSED_MF MS-FINDER 2.923; C12H37N7O2S; [M+H]+; delta(ppm) 0.767084
COMMENT: PROPOSED_MF MS-FINDER 2.688; C15H33N7O2; [M+H]+; delta(ppm) 10.559001
COMMENT: PROPOSED_MF MS-FINDER 2.437; C20H33N5; [M+H]+; delta(ppm) -1.125597
COMMENT: PROPOSED_MF MS-FINDER 2.281; C15H41N3OS2; [M+H]+; delta(ppm) 11.919540
COMMENT: PROPOSED_MF MS-FINDER 2.220; C17H37N5S; [M+H]+; delta(ppm) -10.917285
COMMENT: PROPOSED_MF SIRIUS5_Sirius 12.700; C19H37NO4; [M+H]+; delta(ppm) 2.759073
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C19H37NO4; [M+H]+; delta(ppm) 2.759073
COMMENT: PROPOSED_MF SIRIUS6_Sirius 21.868; C19H37NO4; [M+H]+; delta(ppm) 2.759073
COMMENT: PROPOSED_MF SIRIUS6_Sirius 10.007; C17H34FN5O; [M+H]+; delta(ppm) -4.444541
COMMENT: PROPOSED_MF SIRIUS6_Sirius 6.450; C7H31N14O2; [M+H]+; delta(ppm) -6.485276
COMMENT: PROPOSED_MF SIRIUS6_Sirius 0.416; C20H33N5; [M+H]+; delta(ppm) -1.125597
COMMENT: PROPOSED_MF SIRIUS6_Sirius -0.358; C18H38N3OP; [M+H]+; delta(ppm) -5.923299
COMMENT: PROPOSED_MF SIRIUS6_Sirius -0.970; C5H29N17O; [M+H]+; delta(ppm) -2.585399
COMMENT: PROPOSED_MF SIRIUS6_Sirius -1.366; C17H37N5S; [M+H]+; delta(ppm) -10.917285
COMMENT: PROPOSED_MF SIRIUS6_Sirius -1.370; C20H40O2P; [M+H]+; delta(ppm) -9.823150
COMMENT: PROPOSED_MF SIRIUS6_Sirius -2.003; C18H41NOSi2; [M+H]+; delta(ppm) -156638.488601
COMMENT: PROPOSED_MF SIRIUS6_Sirius -2.315; C22H35N2O; [M+H]+; delta(ppm) -5.025485
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C19H37NO4; [M+H]+; delta(ppm) 2.759073
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 11.000; FUJLYHJROOYKRA-QGZVFWFLSA-N; C19H37NO4; LAUROYLCARNITINE
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 1.000; FUJLYHJROOYKRA-UHFFFAOYSA-N; C19H37NO4; O-dodecanoylcarnitine
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.489; FUJLYHJROOYKRA-AGDOHHJYNA-N; [M+H]+; CCCCCCCCCCCC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.526; BFVRFWIQTACAPT-AGDOHHJYNA-N; [M+H]+; CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.524; KGDBSAYTYOBZHB-UHFFFAOYNA-N; [M+H]+; CCCCCCCC(O)=NCC(CO)OC(=O)CCCCCCC
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.433; GJGJROWYIOPAIR-UHFFFAOYSA-N; [M+H]+; CCCCCCCC(=O)C(CCCCCC)C(=O)NC(C)(CO)O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.433; IEWHONSDBIATGX-UHFFFAOYSA-N; [M+H]+; O=C(O)CNC(=O)CC(O)CCCCCCCCCCCCCC
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.020; FUJLYHJROOYKRA-AGDOHHJYNA-N; [M+H]+; Dodecanoylcarnitine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.378; KGDBSAYTYOBZHB-UHFFFAOYNA-N; [M+H]+; 1,2-dioctanoyl-1-amino-2,3-propanediol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.306; IEWHONSDBIATGX-UHFFFAOYSA-N; [M+H]+; 2-(3-hydroxyheptadecanamido)acetic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.165; GJGJROWYIOPAIR-UHFFFAOYSA-N; [M+H]+; N-(1,2-dihydroxypropan-2-yl)-2-hexyl-3-oxodecanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.080; CGYVFCHCRBGGJG-UHFFFAOYSA-N; [M+H]+; N-(1,3-dihydroxypropan-2-yl)-2-hexyl-3-oxodecanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.970; BFVRFWIQTACAPT-AGDOHHJYNA-N; [M+H]+; N-palmitoyl serine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; FUJLYHJROOYKRA-AGDOHHJYNA-N; [M+H]+; Dodecanoylcarnitine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.795; KGDBSAYTYOBZHB-UHFFFAOYNA-N; [M+H]+; 1,2-dioctanoyl-1-amino-2,3-propanediol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.763; IEWHONSDBIATGX-UHFFFAOYSA-N; [M+H]+; 2-(3-hydroxyheptadecanamido)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.614; BFVRFWIQTACAPT-AGDOHHJYNA-N; [M+H]+; N-palmitoyl serine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.537; CGYVFCHCRBGGJG-UHFFFAOYSA-N; [M+H]+; N-(1,3-dihydroxypropan-2-yl)-2-hexyl-3-oxodecanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.537; GJGJROWYIOPAIR-UHFFFAOYSA-N; [M+H]+; N-(1,2-dihydroxypropan-2-yl)-2-hexyl-3-oxodecanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 4.000; CGYVFCHCRBGGJG-UHFFFAOYSA-N; [M+H]+; N-(1,3-dihydroxypropan-2-yl)-2-hexyl-3-oxodecanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -2.425; FUJLYHJROOYKRA; [M+H]+; Tocris-0548
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -229.484; KGDBSAYTYOBZHB; [M+H]+; diC8 1-amide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -246.907; IEWHONSDBIATGX; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -314.068; BFVRFWIQTACAPT; [M+H]+; n-palmitoylserine
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.853; FUJLYHJROOYKRA; [M+H]+; Tocris-0548
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -63.040; FUJLYHJROOYKRA; [M+H]+; [(2R)-3-carboxy-2-(12,12,12-trideuteriododecanoyloxy)propyl]-trimethylazanium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -129.880; LZCJTOJTAOKEMD; [M+H]+; 10-Methylundecanoylcarnitine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -134.880; UIFHWVSBOFXYHZ; [M+H]+; 9-Methylundecanoylcarnitine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -155.995; UPEVMSKCAPFMHH; [M+H]+; 6-Methylundecanoylcarnitine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -158.534; KPCPRCIJLYZZDM; [M+H]+; 7-Methylundecanoylcarnitine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -159.535; JNDCDQAZCWZVJE; [M+H]+; 5-Methylundecanoylcarnitine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -160.761; WXOXWSRGMWKIMW; [M+H]+; 8-Methylundecanoylcarnitine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -169.856; DMINJMLGOROIND; [M+H]+; 3-Methylundecanoylcarnitine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -215.128; ATVUXFPVYOVGSN; [M+H]+; 4-Methylundecanoylcarnitine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -350.438; KGDBSAYTYOBZHB; [M+H]+; 1,2-Dioctanoyl-1-amino-2,3-propanediol
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.733; FUJLYHJROOYKRA; [M+H]+; [(2R)-3-carboxy-2-(12,12,12-trideuteriododecanoyloxy)propyl]-trimethylazanium
COMMENT: CONFIDENCE Level 3: Tentative candidate, Dodecanoylcarnitine, FUJLYHJROOYKRA-AGDOHHJYNA-N; Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 CFM-ID:MsfinderDB (1), MS-FINDER:MsfinderDB (1), MetFrag:MsfinderDB (1); This structural isomer was suggested from the biological context HMDB HMDB0002250;
CH$NAME: Dodecanoylcarnitine
CH$NAME: (3R)-3-dodecanoyloxy-4-(trimethylazaniumyl)butanoate
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C19H37NO4
CH$EXACT_MASS: 343.272259
CH$SMILES: CCCCCCCCCCCC(=O)O[C@H](CC(=O)[O-])C[N+](C)(C)C
CH$IUPAC: InChI=1S/C19H37NO4/c1-5-6-7-8-9-10-11-12-13-14-19(23)24-17(15-18(21)22)16-20(2,3)4/h17H,5-16H2,1-4H3/t17-/m1/s1
CH$LINK: CHEBI CHEBI:73054
CH$LINK: HMDB HMDB0002250
CH$LINK: INCHIKEY FUJLYHJROOYKRA-QGZVFWFLSA-N
CH$LINK: LIPIDMAPS LMFA07070062
CH$LINK: PUBCHEM CID:168381
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Feces
AC$INSTRUMENT: UPLC system, AB SCIEX - TripleTOF 5600+ mass spectrometer, AB SCIEX
AC$INSTRUMENT_TYPE: LC-ESI-QTOF
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 30 V
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 5.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 15.00; MS2(ppm) 20.00
AC$CHROMATOGRAPHY: COLUMN_NAME ACQUITY UPLC T3 column (1.8 Âµm, 100 mm x 2.1 mm; Waters)
AC$CHROMATOGRAPHY: FLOW_GRADIENT 0.0-0.5 min, 5% B; 0.5-7.0 min,` 100% B; 7.0-8.0 min, 100% B; 8.0-8.1 min, 5% B; 8.1-10.0 min, 5% B. 
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 3.533
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 344.280485
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-000i-9000000000-e20bea71a4b4d718f8ea
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  57.0697911 33.2963 57.070034 15.1569 24.26 0.7038 20 f{C4H9}/-1.50ppm,p-C15H29N1O4
  60.0805434 86.9709 60.080762 14.1810 33.74 0.8498 27 f{C3H10N1}/-3.87ppm,p-C16H28O4
  81.0695682 23.6689 81.069762 25.9160 20.93 0.5337 20 f{C6H9}/-3.81ppm,p-C13H29N1O4
  85.0281123 999.0000 85.028323 4.7161 0.00 0.8689 28 f{C4H5O2}/-3.45ppm,p-C15H33N1O2
  95.0858234 29.7532 95.086081 16.2064 18.33 0.8097 22 f{C7H11}/3.12ppm,p-C12H27N1O4
  98.9845474 44.8726 98.984824 13.5375 50.44 -0.2583 24 ?
  144.1011376 36.0953 144.101688 11.9291 21.06 0.8450 20 f{C7H14N1O2}/-5.33ppm,p-C12H24O2
  183.1753454 34.1010 183.176365 13.9811 17.93 0.8469 21 f{C12H23O1}/5.48ppm,p-C7H15N1O3
  285.2081023 53.8972 285.210348 14.4526 31.08 0.8886 27 f{C19H27N1O1}/-2.15ppm,p-H11O3
  344.2828910 110.7144 344.282802 13.2362 49.27 1.0000 28 f{C19H38N1O4}/9.75ppm,p
PK$NUM_PEAK: 10
PK$PEAK: m/z int. rel.int.
  57.069791 33.30 33
  60.080543 86.97 86
  81.069568 23.67 23
  85.028112 999.00 999
  95.085823 29.75 29
  98.984547 44.87 44
  144.101138 36.10 36
  183.175345 34.10 34
  285.208102 53.90 53
  344.282891 110.71 110
//
